載入...
Preprogrammed long-term systemic pulsatile delivery of parathyroid hormone to strengthen bone
Parathyroid hormone (PTH) is the only FDA approved anabolic agent for the treatment of osteoporosis. The anabolic action of PTH depends on the mode of PTH adminstration. Pulsatile administration promotes bone formation, however continuous PTH exposure results in bone resorption. In addition, the the...
Na minha lista:
| 發表在: | Adv Healthc Mater |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299037/ https://ncbi.nlm.nih.gov/pubmed/27930873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201600901 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|